InfusionCapital
successfully finds underwriter for Intellicoat
Technology
Orlando, Florida, December
12, 2005 – InfusionCapital today announced that the
company was hired to assist Intellicoat in the selection
of an underwriter in order to meet their capital needs.
After interviewing and introducing many firms to
Intellicoat, Capital Growth Securities was selected
because of their experience and market reputation.
InfusionCapital President,
Kelly McCarthy states, “I’ve enjoyed a long-standing
relationship with Alan and Michael Jacobs, Chairman and
CEO of Capital Growth Securities, and look forward to
working with them in their high quality firm in this
transaction.”
About Intellicoat
Technologies
Intellicoat Technologies
provides single-source, energy-efficient roof and
structural surface coating technology that significantly
reduces energy costs and enhances facility operational
savings. For further information about Intellicoat
Technologies, visit
www.intellicoattech.com.
About Capital Growth
Securities
Capital Growth Securities
Investment Banking efforts focus on identifying and then
affiliating ourselves with well-managed growth companies
exhibiting strong fundamentals and a sustainable
competitive advantage in a Company’s respective field.
Our Investment Banking philosophy differs from most of
Wall Street, as it is relationship-oriented rather than
transactional driven. The Capital Growth Financial
principals have raised close to $500 million in capital
for a variety of financings. For more information,
visit
www.CapitalGrowthFinancial.com.
About InfusionCapital
InfusionCapital provides a
uniquely integrated approach to capital formation. They
have the experience and expertise to guide clients
through complex capital formation processes. They
leverage their years of investment banking experience on
Wall Street, and their long term relationships with
leading portfolio management firms, key investment
managers, and national brokerages to help clients make
the right connections and deliver a consistently
powerful message that gets results. For further
information about InfusionCapital, visit
www.infusioncapital.com.
###
For more information,
contact Gina Andrews, Communications
407-566-1010 or by email at
gina@InfusionCapital.com.
